Variant report
Variant | esv3331673 |
---|---|
Chromosome Location | chr11:75876173-75876517 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs67259330 | chr11:75876173-75876174 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs375997897 | chr11:75876182-75876183 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530264250 | chr11:75876185-75876186 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138411739 | chr11:75876195-75876196 | ZNF genes & repeats Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560479799 | chr11:75876210-75876211 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142962349 | chr11:75876211-75876212 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551623778 | chr11:75876222-75876223 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571476914 | chr11:75876230-75876231 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537237296 | chr11:75876231-75876232 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550403268 | chr11:75876242-75876243 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567022403 | chr11:75876256-75876257 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs192015629 | chr11:75876260-75876261 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552661065 | chr11:75876261-75876262 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561731685 | chr11:75876286-75876287 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79272155 | chr11:75876310-75876311 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368797644 | chr11:75876320-75876321 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184445204 | chr11:75876346-75876347 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113026202 | chr11:75876355-75876356 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188543450 | chr11:75876356-75876357 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368565985 | chr11:75876358-75876359 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575887697 | chr11:75876387-75876388 | ZNF genes & repeats Bivalent/Poised TSS Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544787969 | chr11:75876406-75876407 | Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561419476 | chr11:75876442-75876443 | Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575093159 | chr11:75876444-75876445 | Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534717870 | chr11:75876445-75876446 | Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184026807 | chr11:75876447-75876448 | Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs367962352 | chr11:75876470-75876471 | Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565832634 | chr11:75876474-75876475 | Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189277515 | chr11:75876506-75876507 | Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21482786 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 16608533 | CNVD |
Usher syndrome | 18421352 | CNVD |
Breast cancer | 21858162 | CNVD |
Ovarian cancer | 21240255 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:75873600-75882200 | Weak transcription | Right Atrium | heart |
2 | chr11:75873800-75876400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr11:75873800-75881600 | Weak transcription | Pancreas | Pancrea |
4 | chr11:75874800-75878600 | Weak transcription | Adipose Nuclei | Adipose |
5 | chr11:75876000-75876400 | Weak transcription | Esophagus | oesophagus |
6 | chr11:75876000-75876600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr11:75876000-75876600 | Enhancers | Spleen | Spleen |
8 | chr11:75876200-75876400 | Bivalent/Poised TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr11:75876400-75876600 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
10 | chr11:75876400-75876600 | Flanking Bivalent TSS/Enh | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr11:75876400-75876600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr11:75876400-75876600 | ZNF genes & repeats | Esophagus | oesophagus |